BIOINICIA IS AWARDED GMP CERTIFICATION FOR ITS INDUSTRIAL MANUFACTURING PLANT FOR ELECTROSPUN NANOFIBERS
Paterna, Spain – February 6th, 2018: Spain-based Bioinicia SL announced the GMP (Good Manufacturing Practices) approval for the production of nanofiber-based drug delivery products. Bioinicia is proud to announce that it accomplished cGMP certification for the manufacturing of a first drug-loaded, nanofiber-based pharmaceutical product: the Rivelin® patch, on behalf of one of its clients, Dermtreat ApS. The Rivelin® patch is a breakthrough therapy for the treatment of mucosal diseases. Manufactured at Bioinicia’s industrial-scale nanofiber production facilities, the Rivelin® patch is a novel, multi-component electrospun product designed for the unidirectional delivery of a...